Use of Laparoscopy As an Alternative to Computed Tomography (CT) and Positron Emission Tomography (PET) Scans for the Detection of Recurrence in Patients with Gastric Cancer: a Pilot Study

Overview

Journal Surg Endosc

Publisher Springer

Specialties Gastroenterology
General Surgery
Radiology

Date 2011 May 3

PMID 21533967

Citations 5

Authors

Jung Ho Shim

Han Mo Yoo

Han Hong Lee

Jun Gi Kim

Hae Myung Jeon

Kyo Young Song

Cho Hyun Park

Affiliations

Soon will be listed here.

Abstract

Background: This study aimed to evaluate laparoscopy as a diagnostic method for detecting recurrence in patients with advanced gastric cancer.

Methods: Diagnostic laparoscopy was performed for 12 patients with insufficient evidence of intraabdominal gastric cancer recurrence by computed tomography or positron emission tomography. By comparing laparoscopic observations with conventional radiologic results, the diagnostic accuracy of laparoscopy was assessed.

Results: In 11 (92%) of 12 cases of recurrence not diagnosed by imaging studies, laparoscopic examination confirmed the case as a recurrence. Using diagnostic laparoscopy, retroperitoneal lymph node recurrence was confirmed in two patients, peritoneal seeding nodules in five patients, and recurrent masses invading the mesocolon in two patients. Two patients had no definitive recurrence grossly but were confirmed as recurrence cases by washing cytology during the laparoscopic procedure. One patient had a duodenal stump recurrence. No patients experienced operation-related morbidity.

Conclusion: Laparoscopy is a safe and feasible method for detecting recurrence with acceptable accuracy. This approach provides more accurate information than conventional imaging methods.

Citing Articles

Indication of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer (Gastripec, Gastrichip).

Rau B, Feldbrugge L, Gronau F, Alberto Vilchez M, Thuss-Patience P, Bonnot P Visc Med. 2022; 38(2):81-89.

PMID: 35614895 PMC: 9082209. DOI: 10.1159/000522604.

Evaluation of the recurrence pattern of gastric cancer after laparoscopic gastrectomy with D2 lymphadenectomy.

Kawamura Y, Satoh S, Umeki Y, Ishida Y, Suda K, Uyama I Springerplus. 2016; 5(1):821.

PMID: 27390661 PMC: 4916120. DOI: 10.1186/s40064-016-2535-4.

At which stage of gastric cancer progression do levels of carcinoembryonic antigen and carbohydrate antigen 19-9 increase? Application in advanced gastric cancer treatment.

Han E, Lee H, Lee J, Song K, Park C, Jeon H J Gastric Cancer. 2014; 14(2):123-8.

PMID: 25061540 PMC: 4105377. DOI: 10.5230/jgc.2014.14.2.123.

Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis.

Feng Q, Pei W, Zheng Z, Bi J, Yuan X Cancer Biol Med. 2013; 10(2):86-91.

PMID: 23882423 PMC: 3719191. DOI: 10.7497/j.issn.2095-3941.2013.02.004.

Survival benefit of palliative gastrectomy in gastric cancer patients with peritoneal metastasis.

Tokunaga M, Terashima M, Tanizawa Y, Bando E, Kawamura T, Yasui H World J Surg. 2012; 36(11):2637-43.

PMID: 22820871 DOI: 10.1007/s00268-012-1721-y.

References

De Vita F, Orditura M, Matano E, Bianco R, Carlomagno C, Infusino S . A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. Br J Cancer. 2005; 92(9):1644-9. PMC: 2362040. DOI: 10.1038/sj.bjc.6602573. View

Kim J, Jang Y, Park S, Park S, Mok Y . Benefit of post-operative surveillance for recurrence after curative resection for gastric cancer. J Gastrointest Surg. 2010; 14(6):969-76. DOI: 10.1007/s11605-010-1200-4. View

Park M, Lee W, Lim H, Park K, Choi J, Kim B . Detecting recurrence of gastric cancer: the value of FDG PET/CT. Abdom Imaging. 2008; 34(4):441-7. DOI: 10.1007/s00261-008-9424-4. View

Ichiyoshi Y, Toda T, Minamisono Y, Nagasaki S, Yakeishi Y, Sugimachi K . Recurrence in early gastric cancer. Surgery. 1990; 107(5):489-95. View

De Potter T, Flamen P, Van Cutsem E, Penninckx F, Filez L, Bormans G . Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. Eur J Nucl Med Mol Imaging. 2002; 29(4):525-9. DOI: 10.1007/s00259-001-0743-8. View

Song K, Park S, Kim S, Park C . The role of surgery in the treatment of recurrent gastric cancer. Am J Surg. 2008; 196(1):19-22. DOI: 10.1016/j.amjsurg.2007.05.056. View

Husain A, Chi D, Prasad M, Abu-Rustum N, Barakat R, Brown C . The role of laparoscopy in second-look evaluations for ovarian cancer. Gynecol Oncol. 2001; 80(1):44-7. DOI: 10.1006/gyno.2000.6036. View

Jadvar H, Tatlidil R, Garcia A, Conti P . Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography. Clin Radiol. 2003; 58(3):215-21. DOI: 10.1016/s0009-9260(02)00477-4. View

Yoo C, Noh S, Shin D, Choi S, Min J . Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000; 87(2):236-42. DOI: 10.1046/j.1365-2168.2000.01360.x. View

10.

Parkin D, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2):74-108. DOI: 10.3322/canjclin.55.2.74. View

11.

Littell R, Hallonquist H, Matulonis U, Seiden M, Berkowitz R, Duska L . Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma. Gynecol Oncol. 2006; 103(2):570-4. DOI: 10.1016/j.ygyno.2006.04.011. View

12.

Sarela A, Miner T, Karpeh M, Coit D, Jaques D, Brennan M . Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma. Ann Surg. 2006; 243(2):189-95. PMC: 1448917. DOI: 10.1097/01.sla.0000197382.43208.a5. View

13.

Maehara Y, HASUDA S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K . Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg. 2000; 87(3):353-7. DOI: 10.1046/j.1365-2168.2000.01358.x. View

14.

Otsuji E, Yamaguchi T, Sawai K, Hagiwara A, Taniguchi H, Takahashi T . Recent advances in surgical treatment have improved the survival of patients with gastric carcinoma. Cancer. 1998; 82(7):1233-7. View

15.

Park C, Song K, Kim S . Treatment results for gastric cancer surgery: 12 years' experience at a single institute in Korea. Eur J Surg Oncol. 2007; 34(1):36-41. DOI: 10.1016/j.ejso.2007.03.004. View

16.

Song K, Kim J, Kim S, Park C . Staging laparoscopy for advanced gastric cancer: is it also useful for the group which has an aggressive surgical strategy?. World J Surg. 2007; 31(6):1228-3. DOI: 10.1007/s00268-007-9017-3. View

17.

Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M . S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008; 9(3):215-21. DOI: 10.1016/S1470-2045(08)70035-4. View

18.

Yano M, Tsujinaka T, Shiozaki H, Inoue M, Sekimoto M, Doki Y . Appraisal of treatment strategy by staging laparoscopy for locally advanced gastric cancer. World J Surg. 2000; 24(9):1130-5; discussion 1135-6. DOI: 10.1007/s002680010183. View